Lee, Y., Lee, E., Kim, I., Lee, K., Kim, T. M., Lee, S., . . . Heo, D. S. (2015). Cisplatin-Based Chemotherapy Is a Strong Risk Factor for Thromboembolic Events in Small-Cell Lung Cancer. Cancer Res Treat.
استشهاد بنمط شيكاغوLee, Yun-Gyoo, Eunyoung Lee, Inho Kim, Keun-Wook Lee, Tae Min Kim, Se-Hoon Lee, Dong-Wan Kim, و Dae Seog Heo. "Cisplatin-Based Chemotherapy Is a Strong Risk Factor for Thromboembolic Events in Small-Cell Lung Cancer." Cancer Res Treat 2015.
MLA استشهادLee, Yun-Gyoo, et al. "Cisplatin-Based Chemotherapy Is a Strong Risk Factor for Thromboembolic Events in Small-Cell Lung Cancer." Cancer Res Treat 2015.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.